These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26457597)

  • 21. Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
    Younis MH; Abu-Hijleh HA; Aldahamsheh OO; Abualruz A; Thalib L
    Med Princ Pract; 2020; 29(5):465-472. PubMed ID: 31887730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of fluorine-18 fluorodesoxyglycose-positron emission tomography for treatment monitoring in patients with soft tissue sarcomas.
    Kasper B; Hohenberger P; Strauss LG; Dimitrakopoulou-Strauss A
    Hell J Nucl Med; 2010; 13(1):40-4. PubMed ID: 20411170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.
    Groheux D; Cochet A; Humbert O; Alberini JL; Hindié E; Mankoff D
    J Nucl Med; 2016 Feb; 57 Suppl 1():17S-26S. PubMed ID: 26834096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
    Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M
    AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.
    Tewfik JN; Greene GS
    Curr Probl Diagn Radiol; 2008; 37(4):178-88. PubMed ID: 18502325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
    Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J
    Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.
    Charest M; Hickeson M; Lisbona R; Novales-Diaz JA; Derbekyan V; Turcotte RE
    Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1944-51. PubMed ID: 19593561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
    Comoretto M; Balestreri L; Borsatti E; Cimitan M; Franchin G; Lise M
    Radiology; 2008 Oct; 249(1):203-11. PubMed ID: 18710963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
    AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp.
    Vasanawala MS; Wang Y; Quon A; Gambhir SS
    Clin Nucl Med; 2006 Sep; 31(9):534-7. PubMed ID: 16921276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas.
    Skamene SR; Rakheja R; Dahlstrom KR; Roberge D; Nahal A; Charest M; Turcotte R; Hickeson M; Freeman C
    J Surg Oncol; 2014 Apr; 109(5):410-4. PubMed ID: 24310279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
    Guja KE; Ganjoo KN; Iagaru A
    Semin Nucl Med; 2024 May; 54(3):332-339. PubMed ID: 38433024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET/CT for radiotherapy treatment planning in patients with soft tissue sarcomas.
    Karam I; Devic S; Hickeson M; Roberge D; Turcotte RE; Freeman CR
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):817-21. PubMed ID: 19386424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected].
    Bestic JM; Peterson JJ; Bancroft LW
    Radiographics; 2009; 29(5):1487-500. PubMed ID: 19755607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET in the Diagnostic Management of Soft Tissue Sarcomas of Musculoskeletal Origin.
    Katal S; Gholamrezanezhad A; Kessler M; Olyaei M; Jadvar H
    PET Clin; 2018 Oct; 13(4):609-621. PubMed ID: 30219191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of 18F fluorodeoxyglucose positron emission tomography/computed tomography in staging of pediatric sarcomas.
    Tateishi U; Hosono A; Makimoto A; Sakurada A; Terauchi T; Arai Y; Imai Y; Kim EE
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):608-12. PubMed ID: 17805034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET/CT for staging of penile cancer.
    Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
    J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Present and future of FDG-PET/CT in ovarian cancer.
    Kitajima K; Murakami K; Sakamoto S; Kaji Y; Sugimura K
    Ann Nucl Med; 2011 Apr; 25(3):155-64. PubMed ID: 21113691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.